生物标志物 生物标志物
Aleksandra Beric1,2, Wenjing Lin3, Gina Jerome4
1Washington University in Saint Louis, Saint Louis, MO, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究验证了NULISA中枢神经系统小组对阿尔茨海默病 (AD) 研究的验证,确定了新的蛋白质生物标志物,用于早期检测主导ADAD (ADAD) 突变载体.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 遗传学 遗传学 是一个
背景情况:
- 早期发现阿尔茨海默病 (AD) 仍然是一个重大挑战.
- 自体主导AD (ADAD) 突变载体为研究临床前蛋白质组变化提供了一个独特的模型.
- NULISA 中枢神经系统面板能够在最小的脑脊液 (CSF) 容量中对AD和炎症蛋白进行多重分析.
研究的目的:
- 为了验证NULISA中枢神经系统小组对ADAD研究的验证.
- 确定与AD引起突变和症状相关的新型蛋白质生物标志物.
- 评估NULISA平台对于早期AD检测的实用性.
主要方法:
- 从主导性遗传性阿尔茨海默症网络 (DIAN) 队列中对232个CSF样本进行横截面分析.
- 通过测试内部/测试间变异性评估和与已建立的免疫测试 (Lumipulse,ELISA) 相对相关的NULISA测试的验证.
- 使用通用线性模型进行差异丰度分析,以比较突变载体 (症状与非症状) 和非载体.
主要成果:
- NULISA测量结果与已知AD生物标志物 (Aβ40,Aβ42,pTau-181,总Tau) 和新兴标志物 (SNAP25,NRGN,YKL40) 的已知测试结果有很强的相关性 (ρ>0.80).
- 在症状与非症状携带者之间确定了17种不同丰富的蛋白质,在携带者与非携带者之间确定了59种.
- 丰富分析揭示了参与细胞死亡,质激活和粉样β反应的蛋白质.
结论:
- 与已建立的方法相比,NULISA平台提供了可靠和高度相关的测量,验证了其在ADAD研究中的使用.
- 该研究确定了与AD引起突变和症状相关的新型蛋白质,扩大了生物标志物领域.
- 这些发现支持NULISA识别的蛋白质作为AD进展的早期生物标志物的潜力.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516